A Registered Cohort Study of Immune-Mediated Neuropathies

Rituximab in Chronic Inflammatory Demyelinating Polyradiculoneuropathy

NCT06325943 ·Status: COMPLETED ·Phase: PHASE3

Exploratory Study of Predictive Markers of the Therapeutic Response in Patients With Chronic Inflammatory Demyelinating Polyradiculoneuropathy Treated With Intravenous Immunoglobulin

NCT02892890 ·Status: COMPLETED ·Phase: NA

TNFα Monoclonal Antibody for Acute Spinal Cord Injury

NCT04988425 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

InertiaLocoGraphy as a Biomarker of Immunoglobulin Therapy Efficacy in Chronic Inflammatory Demyelinating Polyradiculoneuropathy

NCT04529291 ·Status: WITHDRAWN ·Phase: NA

Study to Evaluate the Efficacy and Safety of CM310 in Subjects With IgG4-related Disease

NCT05728684 ·Status: UNKNOWN ·Phase: NA

Imeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT07032662 ·Status: RECRUITING ·Phase: PHASE2

Subcutaneous Immunoglobulin Treatment for Multifocal Motor Neuropathy

NCT00268788 ·Status: COMPLETED ·Phase: PHASE2

Tongji NADs Cohort

NCT07333196 ·Status: NOT_YET_RECRUITING

CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases

NCT07337785 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Clinical and Electrophysiological Patterns of Chronic Dysimmune Polyneuropathy

NCT05219383 ·Status: NOT_YET_RECRUITING

Hematopoietic Stem Cell Transplantation in Chronic Inflammatory Demyelinating Polyneuropathy

NCT00278629 ·Status: COMPLETED ·Phase: PHASE2

Detection and Characterization of Neurologic Manifestations of Inborn and Acquired Errors of Immunity

NCT06169150 ·Status: RECRUITING

A Study of HY001N in the Treatment of Relapsed or Refractory Neurological Autoimmune Diseases

NCT07265206 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

A Proof of Concept Study With Rituximab in Patients With CIDP Not Responding to Conventional Immune Therapy

NCT05877040 ·Status: UNKNOWN ·Phase: PHASE2

Immunoadsorption Versus Immunoglobulins for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT04881682 ·Status: RECRUITING ·Phase: PHASE2

Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy

NCT00004286 ·Status: COMPLETED ·Phase: PHASE3

JY231 Injection for the Treatment of Relapsed/Refractory Neurologic Immune Disorders

NCT06797024 ·Status: RECRUITING ·Phase: NA

Immunoadsorption for Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT07154524 ·Status: RECRUITING

Precision Diagnosis and Prospective Cohort Study for Myasthenia Gravis: Multicenter Analysis in China

NCT04535843 ·Status: RECRUITING

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Immune Globulin for Chronic Inflammatory Demyelinating Polyneuropathy

NCT00004772 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System

NCT04561557 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Low-dose Interleukin-2 Treatment on Idiopathic Inflammatory Myopathy

NCT04062019 ·Status: UNKNOWN ·Phase: PHASE2

GT719 Injection for Recurrent/Refractory Antibody-mediated Neurological Immune Diseases

NCT07021209 ·Status: RECRUITING ·Phase: PHASE1

Evaluate Efficacy and Safety of Fingolimod 0.5 mg Orally Once Daily Versus Placebo in Chronic Inflammatory Demyelinating Polyradiculoneuropathy Patients.

NCT01625182 ·Status: COMPLETED ·Phase: PHASE3

Transcriptome Analysis of the Peripheral Blood in CIDP

NCT02404298 ·Status: UNKNOWN ·Phase: NA